Navigation Links
Cancer Therapy & Research Center at The University of Texas Health Science Center and Oncolytics Biotech(R) Inc. Announce Multi-Trial Clinical Research Collaboration
Date:2/4/2009

CALGARY, Feb. 4 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY) and the Cancer Therapy & Research Center at The University of Texas Health Science Center in San Antonio, (CTRC at UTHSCSA) announced a broad preclinical and clinical collaboration involving up to five, open-label, Phase 2 studies exploring the use of REOLYSIN(R) in combination with chemotherapy for various cancer indications. These indications are expected to include melanoma, pancreatic cancer, squamous cell lung, liver and K-RAS mutated colorectal cancers in combination with standard chemotherapeutics. This research program is in addition to Phase 2 trials in sarcoma and refractory head & neck cancers, sponsored by Oncolytics that are currently underway at this site.

"As an NCI-designated cancer center, we give a very high priority to approaches that are likely to significantly improve the prognosis of patients with malignant diseases," said Dr Giles, Deputy Director of the CTRC at UTHSCSA. "As Director of our Institute for Drug Development (IDD), I am pleased to specifically dedicate IDD resources toward the further rapid investigation of REOLYSIN(R), an agent which is proving itself in the clinic."

"We're excited that an institution of this caliber is investing in additional research opportunities for REOLYSIN(R)," said Dr. Karl Mettinger, Chief Medical Officer of Oncolytics. "This comprehensive research program will explore additional opportunities for REOLYSIN(R) in cancer treatment, while allowing the Company to focus its resources on developing its pivotal program."

About Oncolytics Biotech Inc.

Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of Phase I a
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. VIDEO from Medialink and International HIFU: New Prostate Cancer Procedure Being Tested in US Clinical Trials
2. Society of Gynecologic Oncologists 40th Annual Meeting on Womens Cancer to Include Sessions on Robotics Surgery
3. Winning the War on Cancer: The Critical Role of Radiation Oncology
4. Oncolytics Biotech Inc. Announces Start of Patient Enrolment in Translational Clinical Trial Investigating REOLYSIN(R) in Patients with Metastatic Colorectal Cancer
5. Research Teams at J. Craig Venter Institute and Ludwig Institute for Cancer Research Uncover New Chromosomal Alterations in Cancer Using Transcriptome Sequencing Approach
6. Pivotal Data Published For First Biomarker Combination Test to Determine Risk of Ovarian Cancer in Women Who Present With Pelvic Mass
7. ThromboGenics and BioInvent Receive Technology Transfer Success Fee From Roche for the Novel Anti-Cancer Antibody, TB-403 (Anti-PIGF)
8. Immunomedics Announces Preclinical Therapy Results of SN-38 Immunoconjugate for Colorectal Cancer
9. Chemoembolization Improving as Liver Cancer Treatment
10. A Milestone in Cancer Genetics: deCODE Discovers First Common Genetic Variants Affecting the Risk of Many Types of Cancer
11. Algeta Completes Comprehensive Phase II Clinical Program With Alpharadin for Treating Bone Metastases in Patients With Advanced Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... CARLSBAD, Calif., May 5, 2015 Isis Pharmaceuticals, ... operating income of $4.0 million for the three months ... net operating loss of $22.6 million for the same ... due to higher revenue from milestone payments earned from ... On a GAAP basis, Isis reported a loss from ...
(Date:5/5/2015)... 2015 Big Market Research presents a detailed ... Europe , ( France , Germany ... , UK) and Japan . Current scientific views ... provides the 5-year test volume and sales forecasts by country for ... Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed ...
(Date:5/5/2015)... 2015  Image Stream Medical, a leader in OR ... one of the largest group purchasing organizations, serving four ... terms of the three-year agreement, Image Stream,s portfolio of ... made available to MedAssets members beginning on July 1, ... Medical CEO Eddie Mitchell said, ...
Breaking Medicine Technology:Isis Reports Financial Results and Highlights for First Quarter 2015 2Isis Reports Financial Results and Highlights for First Quarter 2015 3Isis Reports Financial Results and Highlights for First Quarter 2015 4Isis Reports Financial Results and Highlights for First Quarter 2015 5Isis Reports Financial Results and Highlights for First Quarter 2015 6Isis Reports Financial Results and Highlights for First Quarter 2015 7Isis Reports Financial Results and Highlights for First Quarter 2015 8Isis Reports Financial Results and Highlights for First Quarter 2015 9Isis Reports Financial Results and Highlights for First Quarter 2015 10Isis Reports Financial Results and Highlights for First Quarter 2015 11Isis Reports Financial Results and Highlights for First Quarter 2015 12Isis Reports Financial Results and Highlights for First Quarter 2015 132015 Opportunities in the Global Hepatitis Diagnostic Testing Market: Big Market Research 22015 Opportunities in the Global Hepatitis Diagnostic Testing Market: Big Market Research 3Image Stream Medical Announces Agreement with MedAssets 2
(Date:5/5/2015)... Sunny skies and cool temperatures made for great conditions last ... walkers participated in Global Lyme Alliance’s (GLA) inaugural “Lyme ... 5K and 10K runs and 1-and 3-mile walks were held ... for tick-borne disease research. The “Lyme Walk and Run” was ... of Lyme Research Alliance (LRA) and Tick-Borne Disease Alliance (TBDA), ...
(Date:5/5/2015)... May 05, 2015 Skedans Systems ... Victoria BC announced the Skedans Sensor Collaboration Platform at ... mobile and web app developers, provides tooling to deliver ... mobile sensors. , The Skedans Sensor Collaboration Platform is ... of the Internet of Things, Web Real Time Communications ...
(Date:5/5/2015)... year, PolyU researchers garnered two Grand Prizes, two Special ... and four Silver Medals at the world-renowned event. The ... Prize and Gold Medal with the Congratulations of Jury:, ... Investigator: Dr Allan Chee-kooi CHAN, Institute of Textiles and ... the “mannequin” for many tasks involved in apparel design, ...
(Date:5/5/2015)... 2015 ProTexting, LLC – a ... deploy Mobile Engagement Campaigns and other Mobile solutions, introduces ... can now leverage the power of Mobile Marketing to ... subscribers’ e-mail addresses into the Constant Contact Platform. , ... the growing trend of multi-channel marketing would become more ...
(Date:5/5/2015)... Rare Genomics Institute (RG) today announced ... determining how crowdfunding can promote scientific research to help ... rare disease patients with access to state of the ... and help for payment of these services through grants, ... how crowdfunding will not only help raise much needed ...
Breaking Medicine News(10 mins):Health News:1st Annual “Lyme Walk & Run” Event a Huge Success 2Health News:1st Annual “Lyme Walk & Run” Event a Huge Success 3Health News:Skedans Systems Announces Skedans Sensor Collaboration Platform at AUVSI's Unmanned Systems 2015 in Atlanta 2Health News:PolyU wins top prizes in Geneva’s Invention Expo 2Health News:PolyU wins top prizes in Geneva’s Invention Expo 3Health News:PolyU wins top prizes in Geneva’s Invention Expo 4Health News:PolyU wins top prizes in Geneva’s Invention Expo 5Health News:ProTexting SMS Mobile Marketing platform integrates with Constant Contact 2Health News:ProTexting SMS Mobile Marketing platform integrates with Constant Contact 3Health News:Rare Genomics Institute to Study Impact of Crowdfunding on Rare Diseases 2
... congratulates Jeffrey Crowley, an openly gay man with significant ... his appointment as Director of the Office of National ... dedicated team in the Executive Office of the President,s ... Barnes who has a long standing commitment to HIV/AIDS. ...
... best, south the worst; men and young adults also ... -- The federal government,s push to reduce motor vehicle ... in Massachusetts and the northeast getting the message loud ... -- particularly Mississippi -- are still dying in higher-than-acceptable ...
... Journal of Gerontology: Social Sciences reveals that ... elementary schools are not only more physically active than their ... time. Specifically, those who volunteered burned twice as many calories ... led by Erwin Tan, PhD, of the Johns Hopkins University, ...
... Ltd, B2B, SEO Online PR & Marketing Consultancy, is pleased to ... its already successful Industry Directory, offering free listings to relevant specialist ... ... Marcomms Ltd, B2B, SEO Online PR & Marketing Consultancy , ...
... WASHINGTON, Feb. 26 The chief executive of ... Senate subcommittee today, addressing an alarming new report ... a dangerous shortage of veterinarians available to fill ... DeHaven, CEO of the American Veterinary Medical Association ...
... In the past 12 weeks, two ... Lifesaver, a nationwide tracking program established to quickly locate ... disabilities, such as autism and Alzheimer,s. The program is ... two fathers of children with autism, Sam Spencer and ...
Cached Medicine News:Health News:AIDS Action Applauds President on Appointment of Jeffrey Crowley as Director of National AIDS Policy 2Health News:Car-Crash Death Rates Depend on Where You Live in U.S. 2Health News:Older women find health benefits through volunteer program 2Health News:Simply Marcomms Launch New Specialist Online Industry Directories 2Health News:AVMA Testifies at Senate Hearing on GAO Veterinary Shortage Report 2Health News:AVMA Testifies at Senate Hearing on GAO Veterinary Shortage Report 3Health News:Local Communities Get Serious About Saving Lives Through Project Lifesaver Tracking Equipment, Says NAA 2
... RELISA ENA Single Well Screening Kit is designed ... most common autoantibodies. Each microtiter well is coated ... autoantigens. This allows the laboratory to cost effectively ... to determining the ENA specificity on any of ...
The K-ASSAY Rheumatoid Factor Control Set is intended to be used as a consistent test sample of known concentration for monitoring the performance of K-ASSAY immunoturbidimetric assay for quantifying...
... Lipid Control is intended for use in ... sample of known concentration for monitoring assay ... Liquid Lipid Control with patient serum specimens ... constituents. The user can compare observations with ...
The K-ASSAY Lp(a) Control Set is intended for use as an assayed quality control material for monitoring the performance of Lp(a) immunoturbidimetric assays....
Medicine Products: